Hello from the US..
I just read an article in Fierce Pharma about the FDA issuing a warning letter to Unimark, an API manufacturer in India for unsafe and unsanitary manufacturing practices and lack of testing and records/traceability of testing in their Mumbai facility. The article went on to say that several other manufacturing facilities in India have also been warned. It said that last month, Pan Drugs was also issued a warning letter for the same violations, also saying an "import alert banning any further products from being allowed into the US until the problems were resolved". Just a heads up...haven't heard these companies mentioned from any one who is buying their meds from India., but perhaps good to know...